Next Article in Journal
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
Previous Article in Journal
Special Issue: “Latest Advances on Urological Surgery”
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Metabolic Flexibility and Inflexibility: Pathology Underlying Metabolism Dysfunction

1
School of Health and Consumer Sciences, South Dakota State University, Brookings, SD 57007, USA
2
Department of Kinesiology, Mississippi State University, 180 Magruder Street, Mississippi State, MS 39762, USA
3
School of Kinesiology and Rehabilitation Sciences, University of Central Florida, Orlando, FL 32816, USA
4
College of Health Professions and Sciences, University of Central Florida, Orlando, FL 32816, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(13), 4453; https://doi.org/10.3390/jcm12134453
Submission received: 23 June 2023 / Accepted: 29 June 2023 / Published: 3 July 2023
(This article belongs to the Section Endocrinology & Metabolism)
Metabolic flexibility can be defined as the ability of the skeletal muscle to adjust its utilization of substrate pathways [1]. Timing this metabolic shift to available energy substrates is imperative to transition from the fasted to fed states and from rest to exercise states to meet energy needs. Thus, an inability to rapidly adjust energy substrate utilization has been termed metabolic inflexibility and has recently been associated with obesity, sarcopenia, insulin resistance, type 2 diabetes, and other metabolic chronic conditions [1,2,3]. Metabolic flexibility is typically measured in response to nutritional and exercise challenges with indirect calorimetry to determine energy expenditure from carbohydrates (CHO) and fat utilization [4]. These measurements, along with biomarkers of glucose and insulin, can provide a full picture of metabolic responses to nutritional and exercise stimuli in a variety of populations. Skeletal muscle is necessary for movement and exercise; however, it also has an important role in metabolism, as skeletal muscle accounts for 60–80% of the response of glucose to insulin [1,5]. Thus, to appropriately adjust substrate utilization in response to nutritional and/or exercise stress (i.e., glucose mobilization via insulin), increasing skeletal muscle quality and/or quality should be prioritized. Furthermore, substrate utilization and fuel adaptability are positively associated with exercise performance [6], while numerous dietary and training interventions have been explored to either quantify or manipulate these outcome variables [7,8,9,10]. These assessments can provide a better understanding of key factors related to metabolic flexibility, including physiological factors such as the energy demands of exercise.
The alignment of metabolic inflexibility and disease conditions related to metabolism seems to logically support using an “exercise as medicine” approach for disease improvement. For example, older adults with sarcopenia have lower skeletal muscle mass, strength, and function, and typically experience fat infiltration within skeletal muscle, leading to metabolic impairments that may foundationally contribute to the development of metabolic inflexibility. Recently, Shoemaker et al. examined differences in metabolic flexibility between sarcopenic and non-sarcopenic older adults. This study demonstrated that elderly adults with sarcopenia had greater CHO utilization at rest and post-prandial, and a diminished response to a CHO meal compared to non-sarcopenic elderly adults. Additionally, during aerobic exercise, fat oxidation was lower for the sarcopenic group than the non-sarcopenic group, suggesting an impairment in fat utilization and, thus, metabolic inflexibility, perhaps connected to mitochondrial dysfunction [2]. Conversely, in healthy children, Gillen et al. demonstrated that consumption of a rapid-digesting carbohydrate drink prior to exercise may promote greater exogenous carbohydrate utilization, demonstrating the ability of healthy children to adjust substrate utilization pathways based on dietary intake to maintain endogenous carbohydrate and fat sources, prolonging exercise during low-intensity bouts [11].
Both of these studies emphasize the importance of exercise for metabolic health across the lifespan, which is echoed in recent studies examining the role exercise has in metabolic-related chronic diseases [12,13,14,15]. A recent review highlighted the importance of resistance training for improving outcomes in the early and late stages of frailty and sarcopenia [15]. The conclusion of this review suggested that exercise may be a preventative strategy for preserving skeletal muscle health while highlighting its interrelatedness with chronic disease. Additionally, exercise training can promote metabolic responses, including improved fatty acid oxidation, insulin sensitivity, and mitochondrial content, which likely has corresponding benefits such as reducing insulin resistance, diabetes, cardiovascular disease, and other chronic conditions. For example, in females across the lifespan (ages 20–60 years), a combination of aerobic and resistance training improved risk factors of metabolic syndrome, including waist circumference, fasting blood glucose, blood pressure, and blood lipid parameters [12]. Additionally, Methenitis et al. examined differences in body composition, blood glucose, and lipid concentrations in sedentary compared to endurance-trained middle-aged adults consuming a high-fat diet [14]. This study found that training-induced energy expenditure is the main determinant of these metabolic parameters, as well as positive metabolic adaptations that were more influenced by exercise training rather than nutritional intake. The authors theorized that the training volume resulted in improved mitochondrial density and oxidative capacity, leading to improved regulation of CHO and fat metabolism, thus making endurance-trained individuals more metabolically flexible than sedentary individuals [14]. Similarly, a study assessing functional fitness abilities in individuals with and without metabolic syndrome reported that the fitness level was lower in those with metabolic syndrome, independent of sex and age [13], and individuals with type 2 diabetes and coronary artery disease had low aerobic exercise capacity [16], further supporting the idea that exercise may be an important driver of improving metabolic flexibility.
Across the lifespan, it seems that improvements in metabolic flexibility may also be driven by improvements in lean body mass [17,18]. Oh et al. examined the association of changes in predicted body composition and metabolic health with metabolic syndrome, finding that greater muscle mass reduced the risk of metabolic syndrome in both males and females [17]. Furthermore, it has been demonstrated that adults with low skeletal muscle mass and high adiposity are at greater risk for high glucose, triglycerides, and other biomarkers associated with metabolic health [18]. Since exercise can have a profound effect on increasing lean body mass, even independent of nutritional interventions, it stands to reason that exercise may be an important component of improving metabolic flexibility.
In conclusion, since metabolic flexibility can provide unique insight into metabolic and overall health, it may be pertinent to prioritize specific interventions to affect this important health-related outcome. Based on the current literature, exercise has the potential to act as a “medicine” that may improve metabolic flexibility. In conjunction with appropriate nutritional recommendations, an emphasis on improving muscle quality and quantity through a well-balanced exercise regimen may help individuals improve metabolic flexibility, thus reducing the potential for metabolic diseases and disorders.

Author Contributions

Conceptualization, M.E.S., Z.M.G., D.H.F. and J.T.C.; writing—original draft preparation, M.E.S. and Z.M.G.; writing—review and editing, M.E.S., Z.M.G., D.H.F. and J.T.C. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Goodpaster, B.H.; Sparks, L.M. Metabolic Flexibility in Health and Disease. Cell Metab. 2017, 25, 1027–1036. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Shoemaker, M.E.; Pereira, S.L.; Mustad, V.A.; Gillen, Z.M.; McKay, B.D.; Lopez-Pedrosa, J.M.; Rueda, R.; Cramer, J.T. Differences in muscle energy metabolism and metabolic flexibility between sarcopenic and nonsarcopenic older adults. J. Cachexia Sarcopenia Muscle 2022, 13, 1224–1237. [Google Scholar] [CrossRef] [PubMed]
  3. Prior, S.J.; Ryan, A.S.; Stevenson, T.G.; Goldberg, A.P. Metabolic inflexibility during submaximal aerobic exercise is associated with glucose intolerance in obese older adults. Obesity 2014, 22, 451–457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Yu, E.A.; Le, N.A.; Stein, A.D. Measuring Postprandial Metabolic Flexibility to Assess Metabolic Health and Disease. J. Nutr. 2021, 151, 3284–3291. [Google Scholar] [CrossRef] [PubMed]
  5. Ng, J.M.; Azuma, K.; Kelley, C.; Pencek, R.; Radikova, Z.; Laymon, C.; Price, J.; Goodpaster, B.H.; Kelley, D.E. PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans. Am. J. Physiol. Endocrinol. Metab. 2012, 303, E1134–E1141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Cermak, N.M.; van Loon, L.J.C. The use of carbohydrates during exercise as an ergogenic aid. Sports Med. 2013, 43, 1139–1155. [Google Scholar] [CrossRef] [PubMed]
  7. Rossi, P.A.Q.; Lira, F.S.; Bezerra, V.R.; Clark, N.W.; Fukuda, D.H.; Panissa, V.L.G. Acute Response to Capsiate Supplementation at Rest and during Exercise on Energy Intake, Appetite, Metabolism, and Autonomic Function: A Randomized Trial. J. Am. Nutr. Assoc. 2022, 41, 541–550. [Google Scholar] [CrossRef] [PubMed]
  8. La Monica, M.B.; Fukuda, D.H.; Starling-Smith, T.M.; Clark, N.W.; Panissa, V.L.G. Alterations in energy system contribution following upper body sprint interval training. Eur. J. Appl. Physiol. 2020, 120, 643–651. [Google Scholar] [CrossRef] [PubMed]
  9. Clark, N.W.; Wells, A.J.; Coker, N.A.; Goldstein, E.R.; Herring, C.H.; Starling-Smith, T.M.; Varanoske, A.N.; Panissa, V.L.G.; Stout, J.R.; Fukuda, D.H. The acute effects of thermogenic fitness drink formulas containing 140 mg and 100 mg of caffeine on energy expenditure and fat metabolism at rest and during exercise. J. Int. Soc. Sports Nutr. 2020, 17, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Panissa, V.L.G.; Fukuda, D.H.; Staibano, V.; Marques, M.; Franchini, E. Magnitude and duration of excess of post-exercise oxygen consumption between high-intensity interval and moderate-intensity continuous exercise: A systematic review. Obes. Rev. 2021, 22, e13099. [Google Scholar] [CrossRef] [PubMed]
  11. Gillen, Z.M.; Mustad, V.A.; Shoemaker, M.E.; Mckay, B.D.; Leutzinger, T.J.; Lopez-Pedrosa, J.M.; Rueda, R.; Cramer, J.T. Impact of slow versus rapid digesting carbohydrates on substrate oxidation in pre-pubertal children: A randomized crossover trial. Clin. Nutr. 2021, 40, 3718–3728. [Google Scholar] [CrossRef] [PubMed]
  12. Andrade, D.C.; Flores-Opazo, M.; Peñailillo, L.; Delgado-Floody, P.; Cano-Montoya, J.; Vásquez-Gómez, J.A.; Alvarez, C. Similar Adaptations to 10 Weeks Concurrent Training on Metabolic Markers and Physical Performance in Young, Adult, and Older Adult Women. J. Clin. Med. 2021, 10, 5582. [Google Scholar] [CrossRef] [PubMed]
  13. Gallardo-Alfaro, L.; Bibiloni, M.d.M.; Argelich, E.; Angullo-Martinez, E.; Bouzas, C.; Tur, J.A. Metabolic Syndrome and Functional Fitness Abilities. J. Clin. Med. 2021, 10, 5840. [Google Scholar] [CrossRef] [PubMed]
  14. Methenitis, S.; Feidantsis, K.; Kaprara, A.; Hatzitolios, A.; Skepastianos, P.; Papadopoulou, S.K.; Panayiotou, G. Body Composition, Fasting Blood Glucose and Lipidemic Indices Are Not Primarily Determined by the Nutritional Intake of Middle-Aged Endurance Trained Men-Another “Athletes’ Paradox”? J. Clin. Med. 2022, 11, 6057. [Google Scholar] [CrossRef] [PubMed]
  15. Talar, K.; Hernández-Belmonte, A.; Vetrovsky, T.; Steffl, M.; Kałamacka, E.; Courel-Ibáñez, J. Benefits of Resistance Training in Early and Late Stages of Frailty and Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J. Clin. Med. 2021, 10, 1630. [Google Scholar] [CrossRef] [PubMed]
  16. Schwaab, B.; Windmöller, M.; König, I.R.; Schütt, M. Evaluation of Aerobic Exercise Intensity in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus. J. Clin. Med. 2020, 9, 2773. [Google Scholar] [CrossRef] [PubMed]
  17. Oh, Y.H.; Choi, S.; Lee, G.; Son, J.S.; Kim, K.H.; Park, S.M. Changes in Body Composition Are Associated with Metabolic Changes and the Risk of Metabolic Syndrome. J. Clin. Med. 2021, 10, 745. [Google Scholar] [CrossRef] [PubMed]
  18. Wu, X.; Park, S. An Inverse Relation between Hyperglycemia and Skeletal Muscle Mass Predicted by Using a Machine Learning Approach in Middle-Aged and Older Adults in Large Cohorts. J. Clin. Med. 2021, 10, 2133. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shoemaker, M.E.; Gillen, Z.M.; Fukuda, D.H.; Cramer, J.T. Metabolic Flexibility and Inflexibility: Pathology Underlying Metabolism Dysfunction. J. Clin. Med. 2023, 12, 4453. https://doi.org/10.3390/jcm12134453

AMA Style

Shoemaker ME, Gillen ZM, Fukuda DH, Cramer JT. Metabolic Flexibility and Inflexibility: Pathology Underlying Metabolism Dysfunction. Journal of Clinical Medicine. 2023; 12(13):4453. https://doi.org/10.3390/jcm12134453

Chicago/Turabian Style

Shoemaker, Marni E., Zachary M. Gillen, David H. Fukuda, and Joel T. Cramer. 2023. "Metabolic Flexibility and Inflexibility: Pathology Underlying Metabolism Dysfunction" Journal of Clinical Medicine 12, no. 13: 4453. https://doi.org/10.3390/jcm12134453

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop